---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-083223"
form_type: "8-K"
ticker: "PLUR"
cik: "0001158780"
company_name: "Pluri Inc."
filed_at: "2022-12-28T23:59:59+00:00"
generated_at: "2026-06-20T22:20:09.177580+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Pluri announces cultivated meat JV with Tnuva reaches proof of concept; CEO takes salary cut for equity

## Summary
- Joint venture with Tnuva Group reached proof of concept in cultivated meat development using Pluri's 3D cell platform.
- New biologics partnership with European API manufacturer for liver and gastroenterological disease treatments.
- Company reduced cash burn by ~30% and secured $8.4M new investment via securities purchase agreements.
- CEO Yaky Yanay foregoes $375,000 cash salary over 12 months in exchange for equity grants.
- EU Horizon Europe awarded €7.5M non-dilutive grant for knee osteoarthritis study using PLX-PAD cells.

## SEC filing metadata
- accession: 0001213900-22-083223
- form_type: 8-K
- ticker: PLUR
- cik: 0001158780
- company_name: Pluri Inc.
- filed_at: 2022-12-28T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158780/000121390022083223/0001213900-22-083223-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158780/000121390022083223/ea170946-8k_pluriinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-083223
- JSON: https://secwatch.observer/filing/0001213900-22-083223.json
- Plain text: https://secwatch.observer/filing/0001213900-22-083223.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.